This compound is primarily utilized in pharmaceutical research and development, particularly as a key intermediate in the synthesis of bioactive molecules. Its structure, featuring a trifluoromethyl group and a pyrazolo-pyridine core, makes it valuable in the design of drugs targeting central nervous system disorders, such as anxiety and depression. Additionally, it is explored for its potential in creating compounds with anti-inflammatory and analgesic properties. Its role in medicinal chemistry is significant due to its ability to enhance the pharmacokinetic and pharmacodynamic profiles of drug candidates.